1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: In 2017, the Company’s Board of Directors approved a new $200.0 million share repurchase program for shares of the Company’s common shares that would have expired on June 30, 2020.
−Removed: In June 2020, the Board of Directors approved a 12-month extension of this program which will now expire on June 30, 2021.
+Added: In June 2020, the Company’s Board of Directors approved a 12-month extension to its share repurchase program, through June 30, 2021.
+Added: The extension authorized the Company to repurchase up to approximately $89.4 million worth of common shares, the remaining amount available of the original $200.0 million initially authorized under the share-repurchase program when it commenced on July 1, 2017.
+Added: Subsequent to March 31, 2021, the Company’s Board of Directors approved a further 12-month extension of the current share repurchase program through June 30, 2022.
The repurchases may be made either in the open market or through private transactions, subject to market conditions, applicable legal requirements and other relevant factors.
The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.
−Removed: During the three months ended September 30, 2020, the Company did not repurchase any shares under this program.
−Removed: As at September 30, 2020, the Company has $89.4 million available under its approved repurchase program.
−Removed: In 2019, IMAX China announced that its shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China in an amount not to exceed 10% of the total number of issued shares of IMAX China as at June 6, 2019 (35,605,560 shares).
−Removed: This program expired on the date of the 2020 Annual General Meeting of IMAX China on June 11, 2020.
−Removed: During the 2020 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 11, 2020 (34,848,398 shares).
−Removed: This program will be valid until the 2021 Annual General Meeting of IMAX China.
+Added: The Company did not repurchase any common shares during the three months ended March 31, 2021.
+Added: As of March 31, 2021, the Company has $89.4 million available under its approved repurchase program.
+Added: In 2020, IMAX China announced that its shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 11, 2020 (34,848,398 shares).
+Added: This program will be valid until the 2021 Annual General Meeting of IMAX China, which is scheduled for May 6, 2021.
The repurchases may be made in the open market or through other means permitted by applicable laws.
IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.
−Removed: During the three months ended September 30, 2020, IMAX China did not repurchase any shares under this program.
−Removed: The total number of shares purchased during the nine months ended September 30, 2020, under both the Company and IMAX China’s repurchase plans, does not include any shares purchased in the administration of employee share-based compensation plans.
−Removed: Employment Memorandum, dated September 18, 2020, between IMAX Corporation and Mark Welton.
−Removed: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Richard L.
−Removed: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Patrick McClymont.
−Removed: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Richard L.
−Removed: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated October 29, 2020, by Patrick McClymont.
−Removed: Inline XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: IMAX CORPORATION
−Removed: October 29, 2020
−Removed: /s/ PATRICK MCCLYMONT
−Removed: Patrick McClymont
−Removed: Executive Vice-President & Chief Financial Officer
−Removed: (Principal Financial Officer)
−Removed: October 29, 2020
−Removed: Senior Vice-President, Finance & Controller
−Removed: (Principal Accounting Officer)
+Added: IMAX China did not repurchase any common shares during the three months ended March 31, 2021.
+Added: The total number of shares purchased during the three months ended March 31, 2021 , under both the Company and IMAX China’s repurchase plans, does not include any shares purchased in the administration of employee share-based compensation plans.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.